Skip to content
Non-Current Assets

Total Assets

Moderna Total Assets decreased by 6.9% to $11.49B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.6%, from $12.7B to $11.49B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 11.0% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2017
Last reportedQ1 2026May 1, 2026

How to read this metric

An increase suggests capital expansion or asset accumulation, while a decrease may indicate asset liquidation or depreciation.

Detailed definition

Total assets represent the aggregate value of all current and non-current resources owned by the company, including cash...

Peer comparison

Standard across all industries; peers in biotech typically hold high levels of cash and intellectual property assets.

Metric ID: total_assets

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$16.15B$20.92B$24.67B$27.61B$26.04B$26.06B$25.86B$24.13B$21.88B$19.45B$18.43B$16.73B$15.68B$15.8B$14.14B$12.7B$12.01B$12.14B$12.34B$11.49B
QoQ Change+29.5%+17.9%+11.9%-5.7%+0.0%-0.8%-6.7%-9.3%-11.1%-5.3%-9.2%-6.3%+0.8%-10.5%-10.2%-5.5%+1.0%+1.7%-6.9%
YoY Change+61.2%+24.5%+4.8%-12.6%-16.0%-25.4%-28.7%-30.7%-28.3%-18.8%-23.2%-24.1%-23.4%-23.2%-12.8%-9.6%
Range$11.49B$27.61B
CAGR-6.9%
Avg YoY Growth-11.6%
Median YoY Growth-21.0%

Frequently Asked Questions

What is Moderna's total assets?
Moderna (MRNA) reported total assets of $11.49B in Q1 2026.
How has Moderna's total assets changed year-over-year?
Moderna's total assets decreased by 9.6% year-over-year, from $12.7B to $11.49B.
What is the long-term trend for Moderna's total assets?
Over 5 years (2020 to 2025), Moderna's total assets has grown at a 11.0% compound annual growth rate (CAGR), from $7.34B to $12.34B.
What does total assets mean?
The total value of everything the company owns.